抗组胺药物奥沙米特处理人肺成纤维细胞时诱导 Ca2+ 信号传导和细胞毒性反应,并评估 Ca2+ 螯合剂的保护作用。

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Wei-Zhe Liang, Kai-Wei Hsieh, Zong-Da Yang, Gwo-Ching Sun
{"title":"抗组胺药物奥沙米特处理人肺成纤维细胞时诱导 Ca2+ 信号传导和细胞毒性反应,并评估 Ca2+ 螯合剂的保护作用。","authors":"Wei-Zhe Liang, Kai-Wei Hsieh, Zong-Da Yang, Gwo-Ching Sun","doi":"10.1111/fcp.13040","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oxatomide, an antihistamine drug of the diphenylmethylpiperazine family, has anti-inflammatory effects in airway disease. Because oxatomide was shown to cause diverse physiological responses in several cell models, the impact of oxatomide on Ca<sup>2+</sup> signaling and its related physiological effects has not been explored in IMR-90 human fetal lung fibroblasts.</p><p><strong>Objectives: </strong>This study assessed the effect of oxatomide on cell viability and intracellular free Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) and examined whether oxatomide-induced cytotoxicity through Ca<sup>2+</sup> signaling in IMR-90 cells.</p><p><strong>Methods: </strong>Cell viability was measured by the cell proliferation reagent (WST-1). [Ca<sup>2+</sup>]<sub>i</sub> was measured by the Ca<sup>2+</sup>-sensitive fluorescent dye fura-2.</p><p><strong>Results: </strong>Oxatomide (10-40 μM) concentration dependently reduced cell viability and induced [Ca<sup>2+</sup>]<sub>i</sub> rises in IMR-90 cells. This cytotoxic effect was reversed by chelation of cytosolic Ca<sup>2+</sup> with BAPTA-AM. In terms of Ca<sup>2+</sup> signaling, oxatomide-caused Ca<sup>2+</sup> entry was inhibited by modulators of store-operated Ca<sup>2+</sup> channels (2-APB and SKF96365) and protein kinase C (PKC) inhibitor (GF109203X). Furthermore, oxatomide-induced Ca<sup>2+</sup> influx was confirmed by Mn<sup>2+</sup>-induced quench of fura-2 fluorescence. In a Ca<sup>2+</sup>-free medium, preincubation with the endoplasmic reticulum Ca<sup>2+</sup> pump inhibitor thapsigargin inhibited oxatomide-evoked [Ca<sup>2+</sup>]<sub>i</sub> rises. Conversely, treatment with oxatomide abolished thapsigargin-induced [Ca<sup>2+</sup>]<sub>i</sub> rises. Inhibition of phospholipase C (PLC) with U73122 also inhibited oxatomide-caused [Ca<sup>2+</sup>]<sub>i</sub> rises.</p><p><strong>Conclusion: </strong>In IMR-90 cells, oxatomide-induced cytotoxicity by preceding [Ca<sup>2+</sup>]<sub>i</sub> rises involving PKC-sensitive store-operated Ca<sup>2+</sup> entry and PLC-dependent Ca<sup>2+</sup> release from the endoplasmic reticulum. BAPTA-AM, with its Ca<sup>2+</sup> chelating effects, may be a potential compound for preventing oxatomide-induced cytotoxicity.</p>","PeriodicalId":12657,"journal":{"name":"Fundamental & Clinical Pharmacology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Induction of Ca<sup>2+</sup> signaling and cytotoxic responses of human lung fibroblasts upon an antihistamine drug oxatomide treatment and evaluating the protective effects of Ca<sup>2+</sup> chelating.\",\"authors\":\"Wei-Zhe Liang, Kai-Wei Hsieh, Zong-Da Yang, Gwo-Ching Sun\",\"doi\":\"10.1111/fcp.13040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Oxatomide, an antihistamine drug of the diphenylmethylpiperazine family, has anti-inflammatory effects in airway disease. Because oxatomide was shown to cause diverse physiological responses in several cell models, the impact of oxatomide on Ca<sup>2+</sup> signaling and its related physiological effects has not been explored in IMR-90 human fetal lung fibroblasts.</p><p><strong>Objectives: </strong>This study assessed the effect of oxatomide on cell viability and intracellular free Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) and examined whether oxatomide-induced cytotoxicity through Ca<sup>2+</sup> signaling in IMR-90 cells.</p><p><strong>Methods: </strong>Cell viability was measured by the cell proliferation reagent (WST-1). [Ca<sup>2+</sup>]<sub>i</sub> was measured by the Ca<sup>2+</sup>-sensitive fluorescent dye fura-2.</p><p><strong>Results: </strong>Oxatomide (10-40 μM) concentration dependently reduced cell viability and induced [Ca<sup>2+</sup>]<sub>i</sub> rises in IMR-90 cells. This cytotoxic effect was reversed by chelation of cytosolic Ca<sup>2+</sup> with BAPTA-AM. In terms of Ca<sup>2+</sup> signaling, oxatomide-caused Ca<sup>2+</sup> entry was inhibited by modulators of store-operated Ca<sup>2+</sup> channels (2-APB and SKF96365) and protein kinase C (PKC) inhibitor (GF109203X). Furthermore, oxatomide-induced Ca<sup>2+</sup> influx was confirmed by Mn<sup>2+</sup>-induced quench of fura-2 fluorescence. In a Ca<sup>2+</sup>-free medium, preincubation with the endoplasmic reticulum Ca<sup>2+</sup> pump inhibitor thapsigargin inhibited oxatomide-evoked [Ca<sup>2+</sup>]<sub>i</sub> rises. Conversely, treatment with oxatomide abolished thapsigargin-induced [Ca<sup>2+</sup>]<sub>i</sub> rises. Inhibition of phospholipase C (PLC) with U73122 also inhibited oxatomide-caused [Ca<sup>2+</sup>]<sub>i</sub> rises.</p><p><strong>Conclusion: </strong>In IMR-90 cells, oxatomide-induced cytotoxicity by preceding [Ca<sup>2+</sup>]<sub>i</sub> rises involving PKC-sensitive store-operated Ca<sup>2+</sup> entry and PLC-dependent Ca<sup>2+</sup> release from the endoplasmic reticulum. BAPTA-AM, with its Ca<sup>2+</sup> chelating effects, may be a potential compound for preventing oxatomide-induced cytotoxicity.</p>\",\"PeriodicalId\":12657,\"journal\":{\"name\":\"Fundamental & Clinical Pharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fundamental & Clinical Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/fcp.13040\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fundamental & Clinical Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/fcp.13040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:奥沙米特是一种二苯基甲基哌嗪类抗组胺药物,对气道疾病具有抗炎作用。由于奥沙托酰胺在多个细胞模型中被证明可引起多种生理反应,因此尚未在 IMR-90 人胎肺成纤维细胞中探讨奥沙托酰胺对 Ca2+ 信号转导的影响及其相关生理效应:本研究评估了草铵膦对 IMR-90 细胞活力和细胞内游离 Ca2+ 浓度([Ca2+]i)的影响,并考察了草铵膦是否通过 Ca2+ 信号转导诱导细胞毒性:方法:用细胞增殖试剂(WST-1)测量细胞活力。方法:用细胞增殖试剂(WST-1)测量细胞活力,用 Ca2+ 敏感荧光染料 fura-2 测量 [Ca2+]i:结果:奥沙托胺(10-40 μM)浓度依赖性地降低了 IMR-90 细胞的存活率,并诱导[Ca2+]i 上升。用 BAPTA-AM 螯合细胞膜 Ca2+ 可逆转这种细胞毒性效应。在 Ca2+ 信号转导方面,贮存操作的 Ca2+ 通道调节剂(2-APB 和 SKF96365)和蛋白激酶 C(PKC)抑制剂(GF109203X)抑制了草甘膦引起的 Ca2+ 进入。此外,氧胺诱导的 Ca2+ 流入通过 Mn2+ 诱导的 fura-2 荧光淬灭得到证实。在无 Ca2+ 的培养基中,预孵育内质网 Ca2+ 泵抑制剂硫司加精可抑制氧胺诱导的 [Ca2+]i 上升。相反,用奥沙利酰胺处理则可消除硫司加精诱导的[Ca2+]i 上升。用 U73122 抑制磷脂酶 C(PLC)也能抑制奥沙米德引起的[Ca2+]i 上升:结论:在 IMR-90 细胞中,氧胺诱导的细胞毒性是在[Ca2+]i 上升之前发生的,其中涉及 PKC 敏感的贮存操作 Ca2+ 进入和 PLC 依赖的内质网 Ca2+ 释放。具有 Ca2+ 螯合作用的 BAPTA-AM 可能是一种潜在的化合物,可用于防止氧胺诱导的细胞毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Induction of Ca2+ signaling and cytotoxic responses of human lung fibroblasts upon an antihistamine drug oxatomide treatment and evaluating the protective effects of Ca2+ chelating.

Background: Oxatomide, an antihistamine drug of the diphenylmethylpiperazine family, has anti-inflammatory effects in airway disease. Because oxatomide was shown to cause diverse physiological responses in several cell models, the impact of oxatomide on Ca2+ signaling and its related physiological effects has not been explored in IMR-90 human fetal lung fibroblasts.

Objectives: This study assessed the effect of oxatomide on cell viability and intracellular free Ca2+ concentrations ([Ca2+]i) and examined whether oxatomide-induced cytotoxicity through Ca2+ signaling in IMR-90 cells.

Methods: Cell viability was measured by the cell proliferation reagent (WST-1). [Ca2+]i was measured by the Ca2+-sensitive fluorescent dye fura-2.

Results: Oxatomide (10-40 μM) concentration dependently reduced cell viability and induced [Ca2+]i rises in IMR-90 cells. This cytotoxic effect was reversed by chelation of cytosolic Ca2+ with BAPTA-AM. In terms of Ca2+ signaling, oxatomide-caused Ca2+ entry was inhibited by modulators of store-operated Ca2+ channels (2-APB and SKF96365) and protein kinase C (PKC) inhibitor (GF109203X). Furthermore, oxatomide-induced Ca2+ influx was confirmed by Mn2+-induced quench of fura-2 fluorescence. In a Ca2+-free medium, preincubation with the endoplasmic reticulum Ca2+ pump inhibitor thapsigargin inhibited oxatomide-evoked [Ca2+]i rises. Conversely, treatment with oxatomide abolished thapsigargin-induced [Ca2+]i rises. Inhibition of phospholipase C (PLC) with U73122 also inhibited oxatomide-caused [Ca2+]i rises.

Conclusion: In IMR-90 cells, oxatomide-induced cytotoxicity by preceding [Ca2+]i rises involving PKC-sensitive store-operated Ca2+ entry and PLC-dependent Ca2+ release from the endoplasmic reticulum. BAPTA-AM, with its Ca2+ chelating effects, may be a potential compound for preventing oxatomide-induced cytotoxicity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.30
自引率
6.90%
发文量
111
审稿时长
6-12 weeks
期刊介绍: Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology including: Antimicrobial, Antiviral Agents Autonomic Pharmacology Cardiovascular Pharmacology Cellular Pharmacology Clinical Trials Endocrinopharmacology Gene Therapy Inflammation, Immunopharmacology Lipids, Atherosclerosis Liver and G-I Tract Pharmacology Metabolism, Pharmacokinetics Neuropharmacology Neuropsychopharmacology Oncopharmacology Pediatric Pharmacology Development Pharmacoeconomics Pharmacoepidemiology Pharmacogenetics, Pharmacogenomics Pharmacovigilance Pulmonary Pharmacology Receptors, Signal Transduction Renal Pharmacology Thrombosis and Hemostasis Toxicopharmacology Clinical research, including clinical studies and clinical trials, may cover disciplines such as pharmacokinetics, pharmacodynamics, pharmacovigilance, pharmacoepidemiology, pharmacogenomics and pharmacoeconomics. Basic research articles from fields such as physiology and molecular biology which contribute to an understanding of drug therapy are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信